Rankings
▼
Calendar
LXRX FY 2024 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+2481.5% YoY
Gross Profit
$30M
98.0% margin
Operating Income
-$197M
-634.2% margin
Net Income
-$200M
-644.8% margin
EPS (Diluted)
$-0.63
Cash Flow
Operating Cash Flow
-$179M
Free Cash Flow
-$180M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$298M
Total Liabilities
$152M
Stockholders' Equity
$146M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$1M
+2481.5%
Gross Profit
$30M
-$58M
+152.7%
Operating Income
-$197M
-$172M
-14.8%
Net Income
-$200M
-$177M
-13.1%
← Q4 2023
All Quarters
Q1 2024 →